Identification and characterization of prescription drugs that change levels of 7-dehydrocholesterol and desmosterol
Regulating blood cholesterol (Chol) levels by pharmacotherapy has successfully improved cardiovascular health. There is growing interest in the role of Chol precursors in the treatment of diseases. One sterol precursor, desmosterol (Des), is a potential pharmacological target for inflammatory and ne...
Main Authors: | Phillip A. Wages, Hye-Young H. Kim, Zeljka Korade, Ned A. Porter |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520341833 |
Similar Items
-
The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally[S]
by: Winnie Luu, et al.
Published: (2015-04-01) -
Vulnerability of DHCR7+/− mutation carriers to aripiprazole and trazodone exposure
by: Zeljka Korade, et al.
Published: (2017-11-01) -
Oxidation of 7-dehydrocholesterol and desmosterol by human cytochrome P450 46A1[S]
by: Sandeep Goyal, et al.
Published: (2014-09-01) -
Effect of long-term administration of AY-9944, an inhibitor of 7-dehydrocholesterol Δ7-reductase, on serum and tissue lipids in the rat
by: D. Dvornik, et al.
Published: (1968-09-01) -
Effects of Psychotropic Medication on Somatic Sterol Biosynthesis of Adult Mice
by: Marta Balog, et al.
Published: (2022-10-01)